Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.70
-0.35 (-1.03%)
Apr 2, 2026, 1:18 PM CST

Sofiva Genomics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7286518638767841,042
Market Cap Growth
-18.80%-24.53%-1.51%11.72%-24.75%-4.66%
Enterprise Value
639579784798684906
Last Close Price
33.7030.1539.6040.5335.3745.11
PE Ratio
--46.8175.9818.3318.29
PS Ratio
1.891.691.901.881.582.05
PB Ratio
1.161.041.341.421.251.67
P/TBV Ratio
1.171.051.361.431.261.69
P/FCF Ratio
51.2545.8548.54325.36-14.49
P/OCF Ratio
47.3942.4024.8736.9645.7513.01
EV/Sales Ratio
1.661.501.731.711.381.78
EV/EBITDA Ratio
20.5073.6234.8978.1322.9115.00
EV/EBIT Ratio
----180.5525.71
EV/FCF Ratio
44.9940.7944.10296.41-12.60
Debt / Equity Ratio
0.060.060.080.100.120.14
Debt / EBITDA Ratio
4.524.521.402.501.601.11
Debt / FCF Ratio
2.502.503.0023.62-1.20
Net Debt / Equity Ratio
-0.14-0.14-0.14-0.12-0.15-0.25
Net Debt / EBITDA Ratio
-11.34-11.34-4.13-7.48-3.23-2.64
Net Debt / FCF Ratio
-6.28-6.28-5.22-28.405.87-2.21
Asset Turnover
0.520.520.590.590.610.65
Inventory Turnover
7.057.057.206.827.037.24
Quick Ratio
2.702.702.602.342.192.63
Current Ratio
3.333.333.272.882.793.03
Return on Equity (ROE)
-1.39%-1.39%3.03%1.91%6.89%9.64%
Return on Assets (ROA)
-2.83%-2.83%-0.27%-1.26%0.29%2.80%
Return on Invested Capital (ROIC)
-6.13%-6.19%-0.50%-2.96%0.69%6.98%
Return on Capital Employed (ROCE)
-5.20%-5.20%-0.50%-2.40%0.50%5.00%
Earnings Yield
-1.29%-1.44%2.14%1.32%5.46%5.47%
FCF Yield
1.95%2.18%2.06%0.31%-2.09%6.90%
Dividend Yield
0.89%-0.76%0.49%2.83%4.43%
Payout Ratio
--23.18%185.32%99.88%52.24%
Buyback Yield / Dilution
-0.57%-0.57%-1.28%0.04%-0.40%0.43%
Total Shareholder Return
0.31%-0.57%-0.52%0.53%2.42%4.86%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.